| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | CA2240075A1 Novel benzoylguanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0785191A1 Fused indan derivatives and salts thereof |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784679A1 Cancer treatment by expression of differentiation factor receptor |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0784624A1 Purine and guanine compounds as inhibitors of pnp |
| 07/23/1997 | EP0784613A1 Colchicine derivatives and the therapeutical use thereof |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0784474A2 Parenteral pharmaceutical compositions containing gf120918a |
| 07/23/1997 | EP0784473A1 Inhibitors of farnesyl-protein transferase |
| 07/23/1997 | EP0675895B1 Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer |
| 07/23/1997 | EP0586617B1 Anti-CD3 aglycosylated IgG Antibody |
| 07/23/1997 | EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS |
| 07/23/1997 | CN1155248A Somatostatin binding peptide-metal chelate conjugates |
| 07/23/1997 | CN1154847A Series medicinal preparation for treating cancer and production method thereof |
| 07/22/1997 | US5650538 Organic salts of N,N'-diacetyl cystine |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650494 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/22/1997 | US5650445 3,4-diphenyl-3-hexene |
| 07/22/1997 | US5650425 Anticarcinogenic, antagonist, antitumor agents and antiinflammatory agents |
| 07/22/1997 | US5650424 Antiagglomerants using imidazolidindiones |
| 07/22/1997 | US5650300 Method of producing monoclonal antibodies to oncofetal protein |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/22/1997 | US5650293 Nucleic acid encoding pp60PIK and the methods of making pp60PIK |
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 07/22/1997 | US5650280 Cellubrevin homolog |
| 07/22/1997 | US5650152 Vaccines for antitumor agents |
| 07/20/1997 | CA2195291A1 Bioactive substance k93-0711 1-1 and 1-2, and process for production thereof |
| 07/17/1997 | WO1997025443A1 Metastasis inducing dna's |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 07/17/1997 | WO1997025332A1 Hexacyclic camptothecin analogues, and process for preparing them |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025069A1 Antibodies with reduced net positive charge |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025063A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | WO1997025037A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 07/17/1997 | WO1997025034A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
| 07/17/1997 | DE19601303A1 Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln Novel benzoylguanidine derivatives, processes for their preparation and their use in the preparation of medicaments |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242866A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241559A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 07/17/1997 | CA2241462A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
| 07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof |
| 07/16/1997 | EP0783894A1 Antibodies modified at two separate sites |
| 07/16/1997 | EP0783887A2 Topical compositions for the treatment of hyperproliferative skin disease |
| 07/16/1997 | EP0783886A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783885A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783884A1 Preventive and remedy for diarrhea |
| 07/16/1997 | EP0783579A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783571A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783517A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 07/16/1997 | EP0783326A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 07/16/1997 | EP0783318A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0783305A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783303A1 Use of aromatic halides for treating mammalian cell proliferation |
| 07/16/1997 | EP0726903B1 Matrix metalloprotease inhibitors |
| 07/16/1997 | EP0653936B1 Use of 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| 07/16/1997 | EP0642523B1 Ganglioside analogs |
| 07/16/1997 | EP0452391B1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 07/16/1997 | CN1154705A Organic compound |
| 07/16/1997 | CN1154654A Pharmaceutically stable oxaliplatinum prepn. |
| 07/16/1997 | CN1154241A Compound alkyl camptothecine injection prescription and prepn. process thereof |
| 07/16/1997 | CN1154239A Medicine composition for deep tumor by local treatment, and using same in pharmaceutic application |
| 07/15/1997 | US5648532 Compositions for boron neutron capture therapy and methods thereof |
| 07/15/1997 | US5648485 β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648474 Antitumor |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648385 Retinoid-like compounds |
| 07/15/1997 | US5648382 Angiogenesis inhibitor |
| 07/15/1997 | US5648365 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 07/15/1997 | US5648361 Rapamycin derivatives |
| 07/15/1997 | US5648273 Hepatic growth factor receptor is the MET proto-oncogene |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648233 Annticarcinogenic agents and antitumor agents |
| 07/15/1997 | US5648226 Isolated peptides derived from tumor rejection antigens, and their use |
| 07/15/1997 | US5648078 Monoclonal antibodies |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |